Immunoglobulins (Ig), particularly IgE, are believed to be crucially involved in the pathogenesis of asthma and, equally, in allergic models of the disease. To validate this paradigm we examined homozygous mutant C57BL/6 mice, which are B cell deficient, lacking all Ig. Mice were immunized intraperitoneally with 10 μg ovalbumin (OVA) plus alum, followed by daily (day 14–20) 30 min exposures to OVA aerosol (OVA/OVA group). Three control groups were run: OVA intraperitoneally plus saline (SAL) aerosol (OVA/SAL group); saline intraperitoneally plus saline aerosol; saline intraperitoneally plus OVA aerosol (n = 6–7). Lung and large airway tissues obtained 24 h after the last OVA or SAL exposure were examined by light microscopy and transmission electron microscopy (TEM). The Ig-deficient mice receiving OVA/ OVA treatment had swollen and discolored lungs and exhibited marked eosinophilia both in large airway subepithelial tissue (49.2 ± 12.0 cells/mm basement membrane [BM] versus OVA/ SAL control 1.2 ± 0.3 cells/mm BM; P <0.001), and perivascularly and peribronchially in the lung (49.3 ± 9.0 cells/unit area versus OVA/SAL control 2.6 ± 0.6 cells/unit area; P <0.001). The eosinophilia extended to the regional lymph nodes. TEM confirmed the subepithelial and perivascular localization of eosinophils. Mucus cells in large airway epithelium increased from 1.5 ± 0.8 (OVA/SAL mice) to 39.5 ± 5.7 cells/mm BM in OVA/OVA treated mice (P <0.001). OVA/SAL mice never differed from the other control groups. Corresponding experiments in wild-type mice (n = 6–7 in each group) showed qualitatively similar but less pronounced eosinophil and mucus cell changes. Macrophages and CD4+ T cells increased in lungs of all OVA/OVA-treated mice. Mast cell number did not differ but degranulation was detected only in OVA/OVA-treated wild-type mice. Immunization to OVA followed by OVA challenges thus cause eosinophil-rich inflammation in airways and lungs of mice without involvement of B cells and Ig.
Skip Nav Destination
Article navigation
3 March 1997
Article|
March 03 1997
Allergic Eosinophil-rich Inflammation Develops in Lungs and Airways of B Cell–deficient Mice
Magnus Korsgren,
Magnus Korsgren
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Search for other works by this author on:
Jonas S. Erjef ält,
Jonas S. Erjef ält
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Search for other works by this author on:
Olle Korsgren,
Olle Korsgren
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Search for other works by this author on:
Frank Sundler,
Frank Sundler
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Search for other works by this author on:
Carl G.A. Persson
Carl G.A. Persson
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Search for other works by this author on:
Magnus Korsgren
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Jonas S. Erjef ält
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Olle Korsgren
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Frank Sundler
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Carl G.A. Persson
From the *Department of Physiology and Neuroscience, Lund University Hospital, 221 85 Lund, Sweden; ‡Department of Pharmacology, Astra-Draco, 221 00 Lund, Sweden; §Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden; and ‖Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden
Address correspondence to Magnus Korsgren, Department of Physiology and Neuroscience, Neuroendocrine Cell Biology, E-blocket, University Hospital, 221 85 Lund, Sweden.
1Abbreviations used in this paper: BAL, bronchoalveolar lavage fluids; Cfegs, clusters of free eosinophil granules; EPO, eosinophil peroxidase; PAS, periodic acid–Schiff reagent; SAL, saline; TEM, transmission electron microscopy.
Received:
December 09 1996
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (5): 885–892.
Article history
Received:
December 09 1996
Citation
Magnus Korsgren, Jonas S. Erjef ält, Olle Korsgren, Frank Sundler, Carl G.A. Persson; Allergic Eosinophil-rich Inflammation Develops in Lungs and Airways of B Cell–deficient Mice. J Exp Med 3 March 1997; 185 (5): 885–892. doi: https://doi.org/10.1084/jem.185.5.885
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement